Kay Hagan actually said...
If I reference the IOM report again here, in the United States, use of clinical data in the regulatory review process is defined by the enabling legislation, regulations and FDA's implementation of the legislation and regulations.
Context
Senator Hagan discusses the role of clinical data in regulatory review.
11/14/2011